Home › Retinopathy of Prematurity › NCT06612541
Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity
Who can join
24 Weeks – 34 Weeks · All sexes
Full eligibility criteria
Inclusion Criteria: * Preterm male and female infants born at 24-34 weeks gestational age and weighing \<1500g at birth Exclusion Criteria: * Infants surgically treated for ROP * Infants with significant health concern that would preclude noninvasive retinal imaging as noted by the primary inpatient team
About the study
The goal of this proposal is to develop novel HH-SECTR technology for visualizing and quantifying diagnostic disease features in prematurely born infant retinopathy of prematurity (ROP) patients that lead to more informed clinical decision making. Providing depth-resolved vascular information has not been adequately investigated for its diagnostic potential. Furthermore, we seek to identify disease features not currently accessible by standard examination methods to better inform clinical decisions.
Sponsor: Vanderbilt University Medical Center · Participants: 90 · Started: Feb 1, 2025
Contact the study team
- Irina De la Huerta, MD, PhD · Phone: 615-936-2020
- Marybeth Carter · Phone: 615-936-1639
Official record on ClinicalTrials.gov — NCT06612541
Locations in the U.S.
| Tennessee | Vanderbilt University Medical Center, Nashville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.